Overview: Packed Cell Volume Fluid TestIntroduction: The Packed Cell Volume Fluid Test measures packed cell volume (PCV) in body fluids to diagnose fluid abnormalities, causing swelling or infection. Aligned with 2023 CAP guidelines, it uses hematological methods for high specificity, supporting general screening. This test is critical for guiding diagnosis, treatment planning, and improving outcomes in clinical pathology for patients with suspected fluid abnormalities, such as pleural effusion.
Other Names: PCV Body Fluids Assay, Fluid Hematocrit Test.
FDA Status: Laboratory-developed test (LDT), meeting clinical pathology standards for diagnostic accuracy.
Historical Milestone: PCV testing for fluids began in the 1960s with effusion studies. Hematological methods improved in the 2000s, enhancing diagnostic precision.
Purpose: Measures PCV in body fluids to diagnose fluid abnormalities, guides treatment, and evaluates patients with swelling or infection.
Test Parameters: 1. PCV in Body Fluids
Pretest Condition: No fasting required. Collect body fluid, pleural fluid, or peritoneal fluid. Report history of swelling, infection, or fluid abnormality symptoms.
Specimen: Body Fluid (sterile container, 5-10 mL), Pleural Fluid (sterile container, 5-10 mL), Peritoneal Fluid (sterile container, 5-10 mL). Transport in a biohazard container.
Sample Stability at Room Temperature: 2 hours
Sample Stability at Refrigeration: 24 hours
Sample Stability at Frozen: Not frozen
Medical History: Document swelling, infection, or history of effusions. Include current medications, especially antibiotics or diuretics.
Consent: Written consent required, detailing the tests purpose, fluid abnormality implications, and risks of sample collection.
Procedural Considerations: Uses centrifugation to measure PCV in body fluids. Results are available in 1-2 days, supporting clinical decisions. Performed in laboratories, often for fluid abnormality diagnosis.
Factors Affecting Result Accuracy: Improper sample collection or contamination can affect results. Hemolysis may alter PCV readings.
Clinical Significance: Elevated PCV in fluids confirms effusions or infections, guiding drainage or antibiotics. Normal results may require cytology.
Specialist Consultation: Consult a pulmonologist or internist for result interpretation and treatment planning.
Additional Supporting Tests: Fluid cytology, culture, or imaging (CT/chest X-ray) to confirm fluid abnormality diagnosis.
Test Limitations: Non-specific for certain fluid conditions; clinical correlation is needed. Sample quality affects sensitivity.
References: CAP Fluid Analysis Guidelines, 2023; Archives of Pathology, Light RW, 2022.
